Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBLINGUALGeneric

GONITRO

NITROGLYCERIN

Standard Dose
0.4MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview GONITRO is listed in Drugs@FDA under application 208424 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NITROGLYCERIN Form and strength POWDER;SUBLINGUAL - 0.4MG/PACKET Sponsor POHL BOSKAMP Submission history Latest submission status date: 2016-06-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview GONITRO is listed in Drugs@FDA under application 208424 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NITROGLYCERIN Form and strength POWDER;SUBLINGUAL - 0.4MG/PACKET Sponsor POHL BOSKAMP Submission history Latest submission status date: 2016-06-08 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.